TNFSF10 and lung carcinoma: Recombinant human TRAIL (rhTRAIL) was not as successful as the PBAE/TRAIL-DNA therapy in killing H446 lung cancer cells, which also demonstrated high levels of DR4 protein expression, high levels of DR5, and low levels of DcR1 and DcR2 expression[151].